Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Josep Lluis Parra"'
Autor:
José Baselga, Neal Rosen, Joaquin Arribas, David Cameron, Charles Geyer, Henry Gomez, Maria Koehler, Robert Gagnon, Catherine Ellis, Josep Lluis Parra, Marta Guzman, Gertrudis Sánchez, Pier Davide Angelini, José Jimenez, Claudia Aura, Ludmila Prudkin, Sarat Chandarlapaty, Maurizio Scaltriti
Supplementary Data from Clinical Benefit of Lapatinib-Based Therapy in Patients with Human Epidermal Growth Factor Receptor 2–Positive Breast Tumors Coexpressing the Truncated p95HER2 Receptor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36ab4055c3c0afbef48f7ad680292f73
https://doi.org/10.1158/1078-0432.22442855.v1
https://doi.org/10.1158/1078-0432.22442855.v1
Autor:
José Baselga, Martine Piccart, Evandro de Azambuja, Javier Cortes, Joaquin Arribas, Holger Eidtmann, Catherine Ellis, Lajos Pusztai, Nadia Harbeck, Claudia Aura, José Jimenez, Ludmila Prudkin, Josep Lluis Parra, Violeta Serra, John Winslow, Ahmed Chenna, Christine Campbell, Dominique Agbor-Tarh, Jeff Sperinde, Ian Bradbury, Paolo Nuciforo, Maurizio Scaltriti
Supplementary Table S1. Multivariate Models in the IHC 3+ Subgroup
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::957f7fdf73f5a4fe582600f5b6fb01be
https://doi.org/10.1158/1078-0432.22455398
https://doi.org/10.1158/1078-0432.22455398
Autor:
José Baselga, Martine Piccart, Evandro de Azambuja, Javier Cortes, Joaquin Arribas, Holger Eidtmann, Catherine Ellis, Lajos Pusztai, Nadia Harbeck, Claudia Aura, José Jimenez, Ludmila Prudkin, Josep Lluis Parra, Violeta Serra, John Winslow, Ahmed Chenna, Christine Campbell, Dominique Agbor-Tarh, Jeff Sperinde, Ian Bradbury, Paolo Nuciforo, Maurizio Scaltriti
Purpose: Expression of p95HER2 has been associated with resistance to trastuzumab-based therapy in patients with metastatic breast cancer. Conversely, high levels of HER2 have been linked with increased clinical benefit from anti-HER2 therapy. In thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::162144fb3b8668cd010809687d11883e
https://doi.org/10.1158/1078-0432.c.6523019.v1
https://doi.org/10.1158/1078-0432.c.6523019.v1
Autor:
José Baselga, Neal Rosen, Joaquin Arribas, David Cameron, Charles Geyer, Henry Gomez, Maria Koehler, Robert Gagnon, Catherine Ellis, Josep Lluis Parra, Marta Guzman, Gertrudis Sánchez, Pier Davide Angelini, José Jimenez, Claudia Aura, Ludmila Prudkin, Sarat Chandarlapaty, Maurizio Scaltriti
Purpose: A subgroup of human epidermal growth factor receptor 2 (HER2)–overexpressing breast tumors coexpresses p95HER2, a truncated HER2 receptor that retains a highly functional HER2 kinase domain but lacks the extracellular domain and results in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a837f5e32a513948c40bba407b6363d6
https://doi.org/10.1158/1078-0432.c.6519506
https://doi.org/10.1158/1078-0432.c.6519506
Autor:
José Baselga, Martine Piccart, Evandro de Azambuja, Javier Cortes, Joaquin Arribas, Holger Eidtmann, Catherine Ellis, Lajos Pusztai, Nadia Harbeck, Claudia Aura, José Jimenez, Ludmila Prudkin, Josep Lluis Parra, Violeta Serra, John Winslow, Ahmed Chenna, Christine Campbell, Dominique Agbor-Tarh, Jeff Sperinde, Ian Bradbury, Paolo Nuciforo, Maurizio Scaltriti
Supplementary Figure S1. Distribution of HER2 expression (measured by HERmark) in all patients (left) and in 3+ IHC cohort patients (right). All patient: n=324; IHC3+: n=232.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::653996e5aefa1a00efb039bb23a0d470
https://doi.org/10.1158/1078-0432.22455401.v1
https://doi.org/10.1158/1078-0432.22455401.v1
Autor:
José Baselga, Joaquin Arribas, Josep Lluis Parra, Carlos Garcia-Echeverria, Michel Maira, Serena Di Cosimo, Francesco Atzori, Elisabeth Llonch, Maria Luisa Botero, Marta Guzman, Vanesa Valero, Pieter J.A. Eichhorn, Maurizio Scaltriti, Ben Markman, Violeta Serra
Phosphatidylinositol-3-kinase (PI3K) pathway deregulation is a common event in human cancer, either through inactivation of the tumor suppressor phosphatase and tensin homologue deleted from chromosome 10 or activating mutations of p110-α. These hot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d31e195bbde334d182676163fe5f585b
https://doi.org/10.1158/0008-5472.c.6498147.v1
https://doi.org/10.1158/0008-5472.c.6498147.v1
Autor:
José Baselga, Joaquin Arribas, Josep Lluis Parra, Carlos Garcia-Echeverria, Michel Maira, Serena Di Cosimo, Francesco Atzori, Elisabeth Llonch, Maria Luisa Botero, Marta Guzman, Vanesa Valero, Pieter J.A. Eichhorn, Maurizio Scaltriti, Ben Markman, Violeta Serra
Supplementary Figure 3 from NVP-BEZ235, a Dual PI3K/mTOR Inhibitor, Prevents PI3K Signaling and Inhibits the Growth of Cancer Cells with Activating PI3K Mutations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::630588dfd5d5009ee30d3369acf43349
https://doi.org/10.1158/0008-5472.22376274
https://doi.org/10.1158/0008-5472.22376274
Autor:
José Baselga, Joaquin Arribas, Josep Lluis Parra, Carlos Garcia-Echeverria, Michel Maira, Serena Di Cosimo, Francesco Atzori, Elisabeth Llonch, Maria Luisa Botero, Marta Guzman, Vanesa Valero, Pieter J.A. Eichhorn, Maurizio Scaltriti, Ben Markman, Violeta Serra
Supplementary Figure 1 from NVP-BEZ235, a Dual PI3K/mTOR Inhibitor, Prevents PI3K Signaling and Inhibits the Growth of Cancer Cells with Activating PI3K Mutations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::935602cdf728a6dab71b2156901546ce
https://doi.org/10.1158/0008-5472.22376280
https://doi.org/10.1158/0008-5472.22376280
Autor:
José Baselga, Joaquin Arribas, Josep Lluis Parra, Carlos Garcia-Echeverria, Michel Maira, Serena Di Cosimo, Francesco Atzori, Elisabeth Llonch, Maria Luisa Botero, Marta Guzman, Vanesa Valero, Pieter J.A. Eichhorn, Maurizio Scaltriti, Ben Markman, Violeta Serra
Supplementary Legends 1-4 from NVP-BEZ235, a Dual PI3K/mTOR Inhibitor, Prevents PI3K Signaling and Inhibits the Growth of Cancer Cells with Activating PI3K Mutations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e61162e5cf98cdcc90d77ad1decb7da
https://doi.org/10.1158/0008-5472.22376268.v1
https://doi.org/10.1158/0008-5472.22376268.v1
Autor:
José Baselga, Joaquin Arribas, Josep Lluis Parra, Carlos Garcia-Echeverria, Michel Maira, Serena Di Cosimo, Francesco Atzori, Elisabeth Llonch, Maria Luisa Botero, Marta Guzman, Vanesa Valero, Pieter J.A. Eichhorn, Maurizio Scaltriti, Ben Markman, Violeta Serra
Supplementary Figure 2 from NVP-BEZ235, a Dual PI3K/mTOR Inhibitor, Prevents PI3K Signaling and Inhibits the Growth of Cancer Cells with Activating PI3K Mutations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::609756ad6b9ae87c8524f0b4110071d2
https://doi.org/10.1158/0008-5472.22376277.v1
https://doi.org/10.1158/0008-5472.22376277.v1